2607 fundamentals
An in-depth look to SHANGHAI PHARMACEUTICALS HOLDING CO operating, investing, and financing activities
2607 free cash flow for Q1 24 is -6.77 B HKD. For 2023, 2607 free cash flow was 3.58 B HKD and operating cash flow was 6.87 B HKD.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM